Literature DB >> 10084456

New intervention strategies for reducing antibiotic resistance.

R R Yates1.   

Abstract

Rising antibiotic resistance rates among bacterial pathogens have resulted in increased morbidity and mortality from nosocomial infections. Widespread use of certain antibiotics, particularly third-generation cephalosporins, has been shown to foster development of generalized beta-lactam resistance in previously susceptible bacterial populations. Reduction in the use of these agents (as well as imipenem and vancomycin) and concomitant increases in the use of extended-spectrum penicillins and combination therapy with aminoglycosides have been shown to restore bacterial susceptibility. Studies have shown that education-based methods, as opposed to coercive measures, are effective in changing the prescribing habits of physicians. Cooperative interaction among infectious-disease physicians, clinical pharmacists, microbiology-laboratory personnel, and infection-control specialists is essential to provide useful suggestions regarding antibiotic choice and dosing to the prescribing physician in real time. Several hospitals have implemented antimicrobial resistance management programs based on these findings. The results of these programs validate the use of a multidisciplinary, education-based, antibiotic-resistance management approach.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10084456     DOI: 10.1378/chest.115.suppl_1.24s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

1.  Rapid multiplex PCR assay to identify respiratory viral pathogens: moving forward diagnosing the common cold.

Authors:  Clifton P Layman; Sarah M Gordon; Diane U Elegino-Steffens; Willie Agee; Jason Barnhill; Gunther Hsue
Journal:  Hawaii J Med Public Health       Date:  2013-09

Review 2.  Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections.

Authors:  M Young; G L Plosker
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 3.  Management of antimicrobial use in the intensive care unit.

Authors:  F Alvarez-Lerma; M Palomar; S Grau
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  Optimizing antibiotic therapy in the intensive care unit setting.

Authors:  M H Kollef
Journal:  Crit Care       Date:  2001-06-28       Impact factor: 9.097

5.  A new approach for the discovery of antibiotics by targeting non-multiplying bacteria: a novel topical antibiotic for staphylococcal infections.

Authors:  Yanmin Hu; Alireza Shamaei-Tousi; Yingjun Liu; Anthony Coates
Journal:  PLoS One       Date:  2010-07-27       Impact factor: 3.240

6.  Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa.

Authors:  Philipp M Lepper; Eberhard Grusa; Helga Reichl; Josef Högel; Matthias Trautmann
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

7.  The current practice of skin testing for antibiotics in Korean hospitals.

Authors:  So Hee Lee; Heung Woo Park; Sae Hoon Kim; Yoon Seok Chang; Sun Sin Kim; Sang Heon Cho; Kyung Up Min; You Young Kim
Journal:  Korean J Intern Med       Date:  2010-06-01       Impact factor: 3.165

8.  Photodynamic antimicrobial polymers for infection control.

Authors:  Colin P McCoy; Edward J O'Neil; John F Cowley; Louise Carson; Áine T De Baróid; Greg T Gdowski; Sean P Gorman; David S Jones
Journal:  PLoS One       Date:  2014-09-24       Impact factor: 3.240

9.  Assessment of Antibiotic Utilization Pattern in Treatment of Acute Diarrhoea Diseases in Bishoftu General Hospital, Oromia Ethiopia.

Authors:  Selamawit Tulu; Tarekegne Tadesse; Addisu Alemayehu Gube
Journal:  Adv Med       Date:  2018-05-02

10.  Patient knowledge and perception of upper respiratory infections, antibiotic indications and resistance.

Authors:  Frank A Filipetto; Danesh S Modi; Lucia Beck Weiss; Carman A Ciervo
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.